Table 1.
Demographic characteristics of selected “Eosinophils” and “IgE” cohorts.
| Variable | Eosinophil | IgE |
|---|---|---|
| Total Patients | 975 | 645 |
| Sex | n(%) | n(%) |
| Male | 665 (68.2%) | 421 (65.3%) |
| Female | 310 (31.8%) | 224 (34.7%) |
| Ethnicity | n(%) | n(%) |
| White/Caucasian | 685 (70.3%) | 464 (71.9%) |
| Black/African American | 75 (7.7%) | 39 (6%) |
| Asian or Pacific Islander | 26 (2.7%) | 19 (2.9%) |
| American Indian/Alaska Native | 2 (0.2%) | 2 (0.3%) |
| Other or More Than One Race | 52 (5.3%) | 34 (5.3%) |
| Unknown or Not Reported | 135 (13.8%) | 87 (13.5%) |
| Living | n(%) | n(%) |
| Yes | 883 (90.6%) | 581 (90.1%) |
| No | 84 (8.6%) | 61 (9.4%) |
| Unknown | 8 (0.8%) | 3 (0.5%) |
| Age * (years) | n(%), reference upper limit (cells/μL) | n(%), reference upper limit (IU/mL) |
| <1 | 93 (9.5%), 900 | 59 (9.1%), 34 |
| 1-3 | 61 (6.3%), 500 | 37 (5.7%), 97 |
| 3-4 | 25 (2.6%), 500 | 14 (2.2%), 199 |
| 4-7 | 73 (7.5%), 500 | 44 (6.8%), 307 |
| 7-9 | 48 (4.9%), 500 | 30 (4.7%), 403 |
| 9-13 | 114 (11.7%), 500 | 64 (9.9%), 696 |
| 13-16 | 84 (8.6%), 500 | 48 (7.4%), 629 |
| 16-18 | 52 (5.3%), 500 | 40 (6.2%), 537 |
| >=18 | 425 (43.6%), 500 | 309 (47.9%), 214 |
*Patient age was calculated by the difference between the date of the patient’s last Eosinophil or IgE record and June 15th of their birth year, as exact birth month and date are not available due to confidentially and anonymity of the patients in the registry.